Dr. Passik, a nationally recognized authority in pain and addiction, will help us to continue to provide scientific research and education to healthcare professionals to advance the care of these people who are suffering.
San Diego, CA (PRWEB) December 10, 2012
Millennium Laboratories today announced leading pain and addiction expert, Steven D. Passik, Ph.D., joined its management team as director of clinical addiction research and education and principal investigator for Millennium Research Institute. Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. Millennium Research Institute is a non-profit national research center that helps advance the science and outcome of pain and addiction management through education, research and advocacy.
Dr. Passik will guide the company’s strategy around meeting the needs of addiction professionals through education and research on the use of medication monitoring, drug testing and pharmacogenetic testing to improve outcomes for patients suffering from pain and addiction.
“Chronic pain and addiction inflict an enormous burden on individuals, families, and society,” said James Slattery, CEO of Millennium Laboratories. “Dr. Passik, a nationally recognized authority in pain and addiction, will help us to continue to provide scientific research and education to healthcare professionals to advance the care of these people who are suffering.”
Dr. Passik most recently served on the faculty at Vanderbilt University Medical Center in Nashville, Tenn., as professor of psychiatry and anesthesiology. He was section co-editor for the opioid pain and addiction section of Pain Medicine, served on the editorial board of the Journal of Pain and Symptom Management and has been a reviewer for many peer-reviewed journals, including The Clinical Journal of Pain. Dr. Passik was editor in chief of the National Cancer Institute’s PDQ Supportive Care Editorial Board. He was named a fellow of Division 28 of the American Psychological Association (Psychopharmacology & Substance Abuse) and awarded a Mayday Fund Fellowship in Pain and Society. An author of more than 120 journal articles, 60 book chapters, and 50 abstracts, he speaks nationally and internationally on pain, addiction and the pain/addiction interface. Dr. Passik received his doctorate in clinical psychology from the New School for Social Research, New York, and was a chief fellow, Psychiatry Service at Memorial Sloan-Kettering Cancer Center in New York.
“It is proven that education, medication monitoring and drug detection are critical elements to addiction treatment and, I believe, key to stemming the epidemic of prescription drug abuse facing this country,” said Dr. Passik. “I’m looking forward to the opportunity, after my 25-year career in academia and treating patients, to have even greater reach and influence on the quality of care for these patients who are suffering.”
About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety.
Millennium’s commitment to advancing the science of pain management includes a strong focus on industry research, education and advocacy. Through its association with the Millennium Research Institute, a nonprofit national research center, it has gained respect as a leader in providing healthcare professionals with education and research to advance the management of chronic pain and addiction. More information can be found at http://www.millenniumlabs.com.